San Francisco-based seed biotech accelerator IndieBio has selected client startup BioAesthetics for its next startup cohort and a $250,000 investment. Founder Nick Pashos will participate in an intensive four-month accelerator program at the IndieBio lab facility, receiving mentorship, customer feedback, networking opportunities, pitch development, and more. This program will accelerate the team’s development of a regenerative nipple graft to help breast cancer patients recover and return to normalcy following mastectomies.

April 27, 2017 — Learn more at WWL-TV

The graduate student founders of Instapath Bioptics took home the $12,500 grand prize in the 2017 Novel Tech Challenge, run by the Tulane Office of Technology Transfer. With rapid, high-quality imaging, Instapath aims to improve how biopsies are processed to increase pathology efficiency and reduce repeat biopsies. The team won the competition’s experienced category. Other winners in that category that also work with the Center’s Commercialization team were Viralchemy, developing an anti-viral treatment for dengue fever, and CMDX Biopsy, which has created a new, integrated biopsy punch device to improve skin biopsies.

April 21, 2017 — Learn more at Tulane.edu

The U.S. Department of Energy has selected Advano as one of 114 small businesses nationwide to receive funding and collaborate with national labs to develop critical energy technologies. With $180,000 from the Energy Department’s Small Business Vouchers Pilot, Advano will collaborate with Argonne National Laboratory to develop functionalized silicon nanoparticles for use in lithium-ion batteries. Demand is increasing for these batteries, which are used extensively in electronics, aerospace, and beyond. Based on research from Tulane, Advano is commercializing a technology that lowers the cost of manufacturing nanoparticles to increase battery energy capacity.

April 21, 2017 — Read more at Energy.gov